{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T05:17:32Z","timestamp":1778908652040,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1136\/ard.2005.050443","type":"journal-article","created":{"date-parts":[[2006,4,28]],"date-time":"2006-04-28T00:19:35Z","timestamp":1146183575000},"page":"1473-1477","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Increased disease activity is associated with a deteriorated lipid profile in patients with ankylosing spondylitis"],"prefix":"10.1016","volume":"65","author":[{"given":"V P","family":"van Halm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J C","family":"van Denderen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M J L","family":"Peters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J W R","family":"Twisk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"van der Paardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I E","family":"van der Horst-Bruinsma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R J","family":"van de Stadt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M H M T","family":"de Koning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B A C","family":"Dijkmans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M T","family":"Nurmohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2005.050443_bib1","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1136\/ard.52.3.174","article-title":"Mortality and causes of death in 198 patients admitted to hospital with ankylosing spondylitis","volume":"52","author":"Lehtinen","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2005.050443_bib2","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1056\/NEJM197709152971103","article-title":"Mortality among patients with ankylosing spondylitis not given X-ray therapy","volume":"11","author":"Radford","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2005.050443_bib3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/art.1780230110","article-title":"Ankylosing spondylitis: survival in men with and without radiotherapy","volume":"23","author":"Kaprove","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2005.050443_bib4","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1136\/bmj.284.6314.449","article-title":"Mortality among patients with ankylosing spondylitis after a single treatment course with X-rays","volume":"13","author":"Smith","year":"1982","journal-title":"BMJ"},{"key":"10.1136\/ard.2005.050443_bib5","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.semarthrit.2004.07.010","article-title":"Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis","volume":"34","author":"Peters","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/ard.2005.050443_bib6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1042\/CS20040326","article-title":"Cardiovascular risk parameters in men with ankylosing spondylitis in comparison with non-inflammatory control subjects: relevance of systemic inflammation","volume":"109","author":"Divecha","year":"2005","journal-title":"Clin Sci (London)"},{"key":"10.1136\/ard.2005.050443_bib7","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1749-6632.1994.tb17329.x","article-title":"Detection and treatment of elevated blood lipids and other risk factors for coronary artery disease in youth","volume":"748","author":"Kwiterovich","year":"1995","journal-title":"Ann N Y Acad Sci"},{"issue":"Suppl","key":"10.1136\/ard.2005.050443_bib8","doi-asserted-by":"crossref","first-page":"i62","DOI":"10.1016\/S0002-9149(02)02635-8","article-title":"High density lipoproteins and atherosclerosis","volume":"90","author":"Rader","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1136\/ard.2005.050443_bib9","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0049-0172(92)90017-8","article-title":"Dyslipoproteinemia in the course of active rheumatoid arthritis","volume":"22","author":"Lazarevic","year":"1992","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/ard.2005.050443_bib10","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1161\/hc3501.095214","article-title":"Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-1 and B, and HDL density subfractions: the atherosclerosis risk in communities (ARIC) study","volume":"104","author":"Sharett","year":"2001","journal-title":"Circulation"},{"issue":"Suppl","key":"10.1136\/ard.2005.050443_bib11","first-page":"S300","article-title":"Determinants of significantly lower serum total cholesterol levels in ankylosing spondylitis patients than age-, gender-, and medical service-matched control patients: results of multivariate analysis","volume":"42","author":"Masi","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1136\/ard.2005.050443_bib12","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1136\/ard.59.11.904","article-title":"Lipoproteins and their subfractions in psoriatic arthritis: identification of an atherogenic profile with active joint disease","volume":"59","author":"Jones","year":"2000","journal-title":"Ann Rheum Dis"},{"issue":"Suppl","key":"10.1136\/ard.2005.050443_bib13","first-page":"S104","article-title":"Significantly lower serum triglyceride levels in ankylosing spondylitis patients than age-, gender-, and medical service-matched controls: results of multivariate analysis","volume":"43","author":"Masi","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2005.050443_bib14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0022-2275(20)38390-5","article-title":"Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins","volume":"30","author":"Cabana","year":"1989","journal-title":"J Lipid Res"},{"key":"10.1136\/ard.2005.050443_bib15","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1161\/01.ATV.0000021150.63480.CD","article-title":"Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR study)","volume":"22","author":"Hulthe","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1136\/ard.2005.050443_bib16","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1136\/ard.2005.036491","article-title":"Double-blind, randomised, placebo-controlled study of leflunomide in the treatment of active ankylosing spondylitis","volume":"64","author":"van Denderen","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2005.050443_bib17","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1136\/ard.2004.020875","article-title":"Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis","volume":"63","author":"Calin","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2005.050443_bib18","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of the diagnostic criteria for ankylosing spondylitis; a proposal for the modification of the New York criteria","volume":"27","author":"van der Linden","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2005.050443_bib19","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/rheumatology\/35.1.66","article-title":"The Bath Ankylosing Spondylitis Patient Global Score (BAS-G)","volume":"35","author":"Jones","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.2005.050443_bib20","first-page":"2281","article-title":"A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index","volume":"21","author":"Calin","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2005.050443_bib21","first-page":"2286","article-title":"A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index","volume":"21","author":"Garrett","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2005.050443_bib22","series-title":"Applied longitudinal data analysis for epidemiology. A practical guide","author":"Twisk","year":"2003"},{"key":"10.1136\/ard.2005.050443_bib23","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1002\/sim.1264","article-title":"Multilevel modelling of medical data","volume":"21","author":"Goldstein","year":"2002","journal-title":"J Stat Med"},{"key":"10.1136\/ard.2005.050443_bib24","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0002-9149(02)03309-X","article-title":"Importance of high-density lipoprotein cholesterol and triglyceride levels in coronary heart disease","volume":"91","author":"Sprecher","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1136\/ard.2005.050443_bib25","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1056\/NEJM199908053410604","article-title":"Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol","volume":"341","author":"Rubins","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2005.050443_bib26","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u00e2\u20ac\u201dan inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2005.050443_bib27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S1568-9972(01)00018-0","article-title":"High-density lipoprotein-associated apolipoprotein A-1: the missing link between infection and chronic inflammation?","volume":"1","author":"Burger","year":"2002","journal-title":"Autoimmun Rev"},{"key":"10.1136\/ard.2005.050443_bib28","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1182\/blood.V97.8.2381","article-title":"Apolipoprotein A-1 inhibits the production of interleukin-1\u00ce\u00b2 and tumour necrosis factor-\u00ce\u00b1 by blocking contact-mediated activation of monocytes by T-lymphocytes","volume":"97","author":"Hyka","year":"2001","journal-title":"Blood"},{"key":"10.1136\/ard.2005.050443_bib29","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0167-5273(02)00237-1","article-title":"Cachexia in rheumatoid arthritis","volume":"85","author":"Walsmith","year":"2002","journal-title":"Int J Cardiol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724199931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724199931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2005.050443","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T01:18:06Z","timestamp":1737249486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724199931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S0003496724199931"],"URL":"https:\/\/doi.org\/10.1136\/ard.2005.050443","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased disease activity is associated with a deteriorated lipid profile in patients with ankylosing spondylitis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2005.050443","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Copyright 2006 by Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}